Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: JULY ISSUE PUBLISHED
  • JULY 2021 Issue has been successfully launched on 1 July 2021.

Abstract

EFFECT OF ARIPIPRAZOLE FOR AUTISM SPECTRUM DISORDER

Sona Sabu*

ABSTRACT

Aripiprazole is associated with several intellectual or emotional disabilities. Little evidence exists to support association with specific environmental exposure. Recently there are two novel drugs approved by FDA for treating irritability in autistic population. Aripiprazole is a second generation antipsychotic drug. It has been noted that the probability of causing weight gain is lower rate in aripiprazole than other atypical antipsychotics. It is approved by FDA for the use of upto 15 mg/day for both autistic children and adolescents.

Keywords: Aripiprazole, Autism, Weight gain, Antipsychotics.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More